I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inno-Gene SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Revenue
zł462k
CAGR 3-Years
-68%
CAGR 5-Years
-28%
CAGR 10-Years
-19%
M
Medicofarma Biotech SA
WSE:MDB
Revenue
zł750.8k
CAGR 3-Years
-41%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Revenue
zł63.6m
CAGR 3-Years
260%
CAGR 5-Years
22%
CAGR 10-Years
10%
S
Selvita SA
WSE:SLV
Revenue
zł329m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inno-Gene SA
Glance View

Market Cap
17.7m PLN
Industry
Life Sciences Tools & Services

Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

IGN Intrinsic Value
2.03 PLN
Overvaluation 60%
Intrinsic Value
Price
I

See Also

What is Inno-Gene SA's Revenue?
Revenue
462k PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Revenue amounts to 462k PLN.

What is Inno-Gene SA's Revenue growth rate?
Revenue CAGR 10Y
-19%

Over the last year, the Revenue growth was -98%. The average annual Revenue growth rates for Inno-Gene SA have been -68% over the past three years , -28% over the past five years , and -19% over the past ten years .

Back to Top